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Abstract The 12/15-lipoxygenase(s) (LOX), poly(ADP-
ribose) polymerase (PARP-1) activity and mitochondrial
apoptosis inducing factor (AIF) protein in the amyloid b
(Ab) toxicity were investigated in PC12 cells that express
either wild-type (APPwt) or double Swedish mutation
(APPsw) forms of human Ab precursor protein. Different
levels of Ab secretion and free radicals formation charac-
terize these cells. The results demonstrated a relationship
between the Ab levels and LOX protein expression and
activity. High Ab concentration in APPsw cells correlated
with a signiﬁcant increase in free radicals and LOX acti-
vation, which leads to translocation of p65/NF-jB into the
nucleus. An increase in AIF expression in mitochondria
was observed concurrently with inhibition of PARP-1
activity in the nuclear fraction of APPsw cells. We sug-
gested that AIF accumulation in mitochondria may be
involved in adaptive/protective processes. However, inhi-
bition of PARP-1 may be responsible for the disturbances
in transcription and DNA repair as well as the degeneration
of APP cells. Under conditions of increased nitrosative
stress, evoked by the nitric oxide donor, sodium nitro-
prusside (SNP, 0.5 mM), 70–80% of all cells types died
after 24 h, signiﬁcantly more in APPsw cells. There was no
further signiﬁcant change in mitochondrial AIF level and
PARP-1 activity compared to corresponding non-treated
cells. Only one exception was observed in PC12 control,
where SNP signiﬁcantly inhibits PARP-1 activity. More-
over, SNP signiﬁcantly activated gene expression for
12/15-LOX in all types of investigated cells. Inhibitors of
all LOX isoforms and speciﬁc inhibitor of 12-LOX
enhanced the survival of cells that were subjected to SNP.
We conclude that the LOX pathways may play a role in Ab
toxicity and in nitrosative-stress-induced cell death and that
inhibition of these pathways offers novel protective
strategies.
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AA Arachidonic acid
AIF Apoptosis-inducing factor
APP Amyloid precursor Protein
APPsw PC12 cells transfected with an expression
vector containing double Swedish-mutated
APP gene
APPwt PC12 cells transfected with an expression
vector containing wild—type APP gene
DCF 20,7-dichloroﬂuorescein
DMSO Dimethyl sulfoxide
G418 An antibiotic used for selection of plasmid-
bearing strains
H2DCFDA 20,7-dichloroﬂuorescein diacetate
LOX Lipoxygenase
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Introduction
Alzheimer‘s disease (AD) is a progressive neurodegener-
ative disorder characterized by the presence of amyloid b
senile plaques. Other typical changes in AD include the
following: tau protein-containing neuroﬁbrillary tangles,
degeneration of axons and dendrites, synaptic failure and
neuronal cell death. The amyloid beta (Ab) peptides are the
crucial components responsible for AD pathology and are
derived from amyloid precursor proteins (APPs) through an
initial b-secretase degradation followed by a c-secretase
cleavage within the membrane-penetrating domain of APP
[1]. Ab peptides exist in several forms, depending on the
milieu and the oligomerization/ﬁbrillization stage. Ab
peptides have been implicated in free radical formation as
well as alterations in several intracellular and intercellular
signaling pathways [2–5]. Numerous hypotheses exist
regarding the role of Ab peptides in the pathogenesis of
AD. Some data suggest a direct action of Ab oligomers [6]
whereas other studies provide evidence that the Ab pep-
tides activate cell surface receptors [7] or alter the immune
response [8]. Cyclooxygenases (COXs) and lipoxygenases
(LOXs) contribute to oxidative stress and AD pathogene-
sis. Moreover, it was observed that COX-2 expression
could be one of the early events in Ab toxicity occurring
during the ﬁrst stage of AD [8–10]. The Ab-evoked free
radical cascade involves several cellular pathways,
including nitric oxide (NO)-mediated signaling. NO release
leads to the activation of cytosolic phospholipase A2
(cPLA2) and the liberation of arachidonic acid (AA), which
in turn, is metabolized by COX and LOX [2, 4, 11].
The LOX pathway produces leukotrienes, lipoxins, pros-
tanes and other derivates. Several studies suggest that
12/15-LOX is a major source of oxidative stress [12]. In
AD-affected frontal and temporal regions, 12/15-LOX
protein levels were higher compared with controls.
The metabolic products of 12/15-LOX, 12/15-hydro-
xyeicosatetraenoic acids, were also markedly elevated
in AD brains [12, 13]. The increase in the activity of
12/15-LOX metabolic pathway was shown to correlate
with an increasing of oxidative imbalance in the AD brain.
The activation of 12-LOX plays also an important role in
the generation of reactive oxygen species (ROS) and in the
decrease of neurons viability in glucose deprivation/reload
conditions [14]. The data from Lebeau et al. [15] showed
that blockade of 12-LOX expression protected cortical
neurons from Ab- induced c-Jun-dependent apoptosis. That
study suggested that 12-LOX might represent a new target
for the treatment of AD. The Ikonomovic et al. [16] data
indicated that intracellular 5-LOX level is the hallmark of
AD pathological lesions. Firuzi et al. [17] reported that
5-lipoxygenase gene disruption reduces Ab pathology in a
model of AD. These ﬁndings suggested that LOXs might
signiﬁcantly contribute to the pathogenesis of the neuro-
degenerative processes in AD.
Consequently, Ab-mediated oxidative stress alters the
function of the DNA-bound enzyme, PARP-1, and several
ion channel-coupled receptors, signaling pathways and
mitochondrial processes [18–21].
Alteration of PARP inﬂuences the function of numerous
transcription factors, including p53, NF-jB, AP-1 and
more than 40 other nuclear proteins [22–26]. In addition to
its basic role in local chromatin disassembly and the efﬁ-
cient positioning of DNA repair machinery, PARP over-
activation can induce cell death [27, 28].
Moreover, the product of the enzyme poly (ADP-ribose)
(PAR) can function as a death signaling molecule leading
to liberation of apoptosis-inducing factor (AIF) from the
mitochondria and its translocation to the nucleus [29–32].
Under resting conditions, AIF is anchored to the inner
mitochondrial membrane where it acts as a complex I
stabilizer and functions as an NADH oxidase [33]. Our
previous results suggest a pro-survival role of AIF accu-
mulation in mitochondria under conditions of nitrosative
stress evoked by the NO donor, sodium nitroprusside
(SNP) [34]. Based on our current knowledge, we suggest
that PARP-1 and AIF can be considered as molecular tar-
gets for Ab mediated signaling.
The aim of our study was to investigate the role of
LOXs, AIF and PARP-1 in Ab-evoked oxidative stress
signaling in PC12 cells that were subjected to nitrosative
stress; these cells were either transfected with wild type
human amyloid precursor protein gene (APPwt) or carried
a double Swedish mutation (APPsw).
Materials and Methods
Materials
The reagents and antibodies were obtained as follows: ECL
reagents were purchased from GE Healthcare, Piscataway
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123NJ, USA; anti-12/15 LOX antibody was obtained from
Cayman Chemical, Ann Arbor MI, USA; anti-b-actin IgG
was acquired from MP Biomedicals, Irvine CA, USA; anti-
cytochrome c was purchased from BD Pharmingen, SD,
USA anti-AIF and anti-p65 IgG were purchased from Santa
Cruz Biotechnology, Santa Cruz CA, USA; anti-mouse IgG
was obtained from GE Healthcare, Piscataway NJ, USA;
and anti-PARP-1 antibody, anti-rabbit IgG and other bio-
chemical and inorganic reagents were acquired from
Sigma, St. Louis MO, USA.
Cell Culture
Rat pheochromocytoma PC12 cells were kindly provided
by Prof. Walter E. Mu ¨ller and Prof. A. Eckert from the
Department of Pharmacology Biocenter (University of
Frankfurt, Germany). The PC12 cells used for the experi-
ments contained DNA expression constructs harboring
human wild-type (APPwt) or mutant APP gene (APPsw,
K670 M/N671L) inserted downstream of a cytomegalovi-
rus promoter [4]. Cells transfected with an empty vector
were used as controls. The cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium supplemented with 10%
fetal bovine serum, 5% horse serum, 50 units/ml penicillin,
50 lg/ml streptomycin, 400 lg/ml G418 and 2 mM glu-
tamine at 37C in a humidiﬁed incubator containing 5%
CO2. Cells were subcultured approximately twice a week
after achieving 80% conﬂuency. For experiments, conﬂu-
ent cells were subcultured into polyethyleneimine-coated
10-cm dishes or 24-well plates and were used at 75–90%
conﬂuence or 1 day after being plated into 24-well plates.
Prior to treatment, the used media was replaced with fresh
media containing 2% fetal bovine serum. PC12, APPwt,
and APPsw cell lines secreted Ab peptide in increasing
amounts as previously described [2].
Cell Treatment Protocols
PC12 cells were treated with SNP at 0.5 mM for various
times up to 24 h. Additionally LOX inhibitors [2.5 lM
baicalein or 0.5 lM nordihydroguaiaretic acid (NDGA)]
were used together with 0.5 mM SNP.
Isolation of Cytosolic, Mitochondrial and Nuclear
Fractions
Fractinaction of the PC12 cells was made as previously
described by Wang et al. [35]. Cells were washed, scraped
into ice-cold PBS and pelleted at 1,0009 rpm for 3 min at
4C. The pellet was resuspended in hypotonic buffer
(10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, 1 mM
dithiotreitol, 1.5 mM MgCl2, 10 mM KCl and protease
inhibitors cocktail); cell membranes were disrupted by 10
passes through a 26-gauge needle and pelleted at 500g for
10 min at 4C. The pellet (P1, the crude nuclear fraction)
was resuspended in 25 mM Tris, pH 7.4 with protease
inhibitors and used for western blot analysis. The super-
natant (S1) was centrifuged at 15,000g for 15 min at 4Ct o
obtain a cytosolic (S2) and a crude mitochondrial fraction
(P2). The immunochemical determination of typical mito-
chondrial protein, cytochrome c, demonstrated that it is
exclusively present in the mitochondria fraction, and indi-
cated concomitantly that other subcellular fractions (nuclear
and cytosolic) are not contaminated by mitochondria.
Then immunochemical detection of DNA bound
enzyme PARP-1 was observed exclusively in nuclear
fraction and has never been detected by us in mitochondrial
and cytosolic fractions. It indicated that the other subcel-
lular fractions are not contaminated.
Determination of Amyloid b1-40
Cells were plated at equal density in 6-well plates. After
reaching conﬂuence, 2 ml of conditioned media was col-
lected. Media were centrifuged to remove cell fragments,
and aliquots were then used to determine the Ab1–40 level.
For determination of secreted Ab1–40, a speciﬁc sand-
wich enzyme linked immunosorbent assay (ELISA)
employing monoclonal antibodies was used. The ELISA
was performed according to the instructions given in the
Ab-ELISA kit by Genetics Company. The assay principle
is that of a standard sandwich ELISA, which utilizes a site-
speciﬁc rabbit anti-human N-terminal capture, a cleavage
sitespeciﬁc rabbit anti-human Ab1–40 terminal detection
antibody, and anti-rabbit IgG peroxidase-conjugated sec-
ondary antibody.
Determination of Free Radicals Using DCF Probe
ROS production in PC12 cells was assessed by using the
20,70-dichlorodihydroﬂuorescein diacetate (H2DCF-DA)
probe. The cell media was changed to Phenol Red-free
Hanks’ buffer and incubation was continued in the pres-
ence of 10 lM H2DCF-DA for 50 min at 37C. Cells were
washed three times in Hanks’ buffer and lysed with
DMSO. The ﬂuorescence (excitation 485 nm and emission
535 nm) was quantiﬁed in the lysate by using a LS-50B
Spectroﬂuorimeter (Perkin Elmer).
MTT Reduction Assay
Cell viability and mitochondrial function were evaluated
using 2-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT). PC12 cells were seeded onto 24-well
culture plates coated with 0.1% polyethyleneimine in
25 mM borate buffer and allowed to attach. Media
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123containing 2% fetal bovine serum, 50 units/ml penicillin,
50 lg/ml streptomycin, and 0.5 mM SNP was added to the
cells for a given period of time. MTT was then added to all
wells and the cells were incubated at 37C for 2 h, fol-
lowed by lysis of the cells and spectrophotometric mea-
surement at 595 nm.
Measurement of PARP-1 Activity
PARP activity was determined using
14C-labeled b-NAD
?
as described previously Strosznajder et al. [27, 28]. The
incubation mixture contained 200 lM [adenine-
14C]
b-NAD
? (4 9 10
5 d.p.m.), 100 mM Tris/HCl buffer (pH
8.0), 10 mM MgCl2, 5 mM DTT, 50 lM PMSF and
200 lg of protein in a ﬁnal volume of 100 ll. The mixture
was incubated for 1 min at 37C and the reaction was
stopped with 0.8 ml of ice-cold 25% trichloroacetic acid.
Precipitates were collected on Whatman GF/B ﬁlters,
washed three times with 5% trichloroacetic acid and left
overnight for drying. The radioactivity was measured in
Bray scintillation ﬂuid using a LKB Wallac 1409 scintil-
lator counter.
Measurement of Lipoxygenase (LOX) Activity
The activity of LOX was determined using the colorimetric
method described by Waslidge and Hayes [36]. The cell
lysate was diluted fourfold on ice with 50 mM Tris–HCl
buffer, pH 7.4, transferred into an ice-cold 96-well plate.
The assay was initiated by the addition of 50 ll arachi-
donic acid (ﬁnal concentration, 70 lM) in 50 mM Tris–
HCl buffer, pH 7.4, and incubated at 37C for 10 min. The
assay was terminated by the addition of 100 ll FOX
reagent: sulfuric acid (25 mM), xylenol orange (100 lM),
iron (II) sulfate (100 lM), methanol:water (9:1). Blanks
contained enzyme during the incubation but substrate was
added after the FOX reagent. The yellow color of the
acidiﬁed xylenol orange was converted to a blue color by
the lipid hydroperoxide-mediated oxidation of Fe
2? ions
and interaction of the resulting Fe
3? ions with the dye.
Absorbance of the ferrium ions complex at 620 nm was
measured using Bio Rad plate reader.
Analysis of mRNA Levels (Real Time PCR for 12/15-
LOX, AIF, PARP-1, b-Actin)
RNA was isolated using TRI-reagent from Sigma. The iso-
lated RNA was dissolved in RNAse-free water (Promega
Corporation). The amount and purity of RNA was deter-
mined using spectrophotometric measurement at 260 and
280 nm.TheOD260/OD280ratio ofthe RNA samples ranged
from 1.6 to 1.9. Isolated RNA (5 lg) was used in RT–PCR.
The reverse transcription was performed by using a High
Capacity cDNA Reverse Transcription Kit according to the
manufacturer’s protocol (Applied Biosystems, Foster City,
CA, USA). Quantitative PCR was performed on an ABI
PRISM 7500 apparatus by using pre-developed TaqMan
Gene Expression Assays (Applied Biosystems, Foster
City, CA, USA) according to the manufacturer’s instruc-
tions: Alox15 (15-LOX) Rn00696151_m1*, Aifm1 (AIF)
m1-Rn00442540_m1,Adpr1- (PARP-1) Rn00565018, Actb
(b-Actin) Rn01412977_g1. Actb was selected and used as a
referencegeneinallstudies.TherelativelevelofmRNAwas
calculated by the DDCt method.
Western Blot
After determination of the total protein content using the
Lowry method, the cytosolic, mitochondrial, or nuclear
fraction was mixed with 59 SDS-containing sample buffer
and denatured for 5 min at 95C. Protein (40 lg/lane) was
loaded onto 10% denaturing polyacrylamide gels and
resolved by SDS–PAGE. The proteins were transferred
onto Polyvinylidene Fluoride membranes at 100 V. Mem-
branes were incubated in 5% fatty acid free dry milk in
TBS (Tris-buffered saline; if not otherwise indicated) with
Tween-20 (TBS-T) for 1 h and were exposed overnight at
4C to the following antibodies: anti-12/15-LOX 1:500;
anti-AIF 1:750; anti-cytochrome c 1:500; anti p65 (in PBS-
T) 1:100; anti-PARP-1 (in PBS-T) 1:500; or anti-actin
1:1,000. After treatment for 1 h with the appropriate
horseradish peroxidase-coupled secondary antibodies
(1:4,000, 1:8,000 anti-rabbit IgG, or 1:2,000, 1:4,000 anti-
mouse IgG), the protein bands were visualized with
enhanced chemiluminescence (GE Healthcare) and auto-
radiographed. The bands were analyzed using TotalLab
TM
densitometry package from Phoretix.
After stripping with a pH 2.5 solution of 50 mM glycine
and 1% sodium dodecyl sulfate (SDS) for 30 min at room
temperature, the membranes were re-used for subsequent
western blot experiments.
Statistical Analysis
All experiments were repeated at least 3 times and were
performed either in triplicate or duplicate. The presented
data are the means ± SEM. For statistical comparison,
Student’s t test or one-way ANOVA followed by Bonfer-
roni post-hoc test were used; P values \0.05 were con-
sidered statistically signiﬁcant.
Results
PC12 cells transfected with human wild-type APP (APPwt)
or APP carrying the double Swedish mutation (APPsw)
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123were used in this study and showed a 2.8 or 4.9-fold higher
1-40 Ab production, respectively, than PC12 control cells
transfected with an empty vector (Fig. 1a). APPwt and
APPsw cells displayed signiﬁcantly increased levels of free
radicals as determined by DCF ﬂuorescence (Fig. 1b).
Moreover, the level of free radicals is signiﬁcantly higher
in APPsw cells comparing to APPwt. The protein
immunoreactivity of 12/15-LOX was enhanced in both
APP transfected cell types, but this enhancement was sig-
niﬁcant in the APPsw cells (Fig. 1c). LOX activity was
also signiﬁcantly higher in APPsw cells indicating a close
relationship between these changes and Ab concentration
(Fig. 1d). We demonstrated previously that a c-secretase
inhibitor (DAPT) effectively decreased the Ab-mediated
release of arachidonic acid (AA), the substrate for LOXs,
indicating a direct involvement of Ab in this processes [2].
The oxidative stress evoked by Ab may lead to the
activation of NF-jB. APPsw cells characterized by high
levels of Ab secretion displayed signiﬁcant enhancement
of p65 (a subunit of the NF-jB) immunoreactivity in the
nuclear fraction (Fig. 2a). Nordihydroguaiaretic acid
(NDGA), an inhibitor of all lipoxygenase isoforms, sig-
niﬁcantly reduced the nuclear translocation of p65 in cells
expressing APPsw (Fig. 2b). Baicalein, a 12/15-lipoxyge-
nase inhibitor, also reduced the nuclear immunoreactivity
of p65, although to a lesser degree (Fig. 2b).
The Ab peptides mediated oxidative stress also inﬂu-
enced mitochondrial function. Our previous data indicated
that a c-secretase inhibitor signiﬁcantly reduced the level of
Ab and mitochondrial dysfunction by normalizing NO and
ATP levels and the mitochondrial membrane potential in
APPsw PC12 cells [4]. In the current study, a statistically
signiﬁcant increase in AIF levels in the mitochondria of
APPsw cells was observed (Fig. 3a). However, AIF
(Aifm1) mRNA level was not altered (Fig. 3a). The
nuclear target for free radical cascade is DNA bound
enzyme PARP-1. The activity of this enzyme was signiﬁ-
cantly decreased in APPsw cells but was not signiﬁcantly
increased in APPwt. (Fig. 3b). In both APP transfected cell
lines, the PARP-1 (Adpr1) mRNA level was not changed
(Fig. 3b). The statistically signiﬁcant alterations in mito-
chondrial AIF levels and PARP-1 activity in the nuclear
fraction were observed in APPsw cells, which are charac-
terized by the highest Ab production.
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Fig. 1 The level of amyloid b secretion, free radicals and LOX
protein expression and activity in APP transfected PC12 cells. a The
cells were transfected with an empty vector (control) or with an
expression vector containing wt (APPwt) or mutated (APPsw) APP
human gene. The amyloid b1-40 secretion was evaluated by
Ab-ELISA kit. b ROS generation in PC12, APPwt, APPsw
cells was estimated using spectroﬂuorescence method (H2DCF-
DA). c 12/15-LOX protein level in APP transfected PC12 cells was
estimated using western blot analysis. A representative western blot
from one typical experiment was selected from 3 independent
experiments. d LOX activity in PC12, APPwt, APPsw cells was
measured using the colorimetric method according to Waslidge and
Hayes [36]. All data represent the mean value ± S.E.M for 3
independent experiments (in triplicate for LOX activity). *P\0.05,
**P\0.01, ***P\0.001 versus control cells
#P\0.05,
##P\0.01
versus APPwt cells, ANOVA with Bonferroni post-hoc test
b
Neurochem Res (2011) 36:839–848 843
123To determine the susceptibility of the APP transfected
cells to additional stress and to evaluate if the observed
pronounced alterations of AIF and PARP-1 in APPsw cells
will be futher changed, NO donor was used in further
experiments.
In the following experiments, all cell lines were sub-
jected to nitrosative stress evoked by sodium nitroprusside
(SNP, 0.5 mM), an NO donor. The western blot signals for
AIF in the mitochondrial fraction and PARP-1 activity
were not changed by SNP as compared to corresponding
SNP untreated controls. The signiﬁcantly lower PARP-1
activity was observed only in SNP-treated PC12 control
cells (data not shown) [34]. Moreover, SNP treatment
signiﬁcantly increased 12/15-LOX gene expression
(determined by the level of Alox15 versus corresponding
controls) in all examined cell lines. More pronounced
activation of 12/15-LOX gene expression in APPsw cells
versus APPwt was observed (Fig. 4a). Under these exper-
imental conditions, SNP decreased the viability of all cells
types by 70–80% after 24 h. APPsw cells displayed a
higher susceptibility to SNP toxicity than PC12 control
cells (Fig. 4b). The LOX inhibitors baicalein and NDGA
signiﬁcantly protected the cells against death caused by
nitrosative stress (Fig. 4c).
Discussion
In our current work, we investigated the level of Ab1-40
secretion, free radicals and the activity of LOX enzymes,
AIF level and PARP-1 activity in Ab-induced oxidative/
nitrosative stress. The studies were performed using cell
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the p65 level. a The effect of endogenous Amyloid b on p65
immunoreactivity. Nuclear p65 protein level in PC12, APPwt, and
APPsw cells was estimated using western blot analysis. A represen-
tative western blot from one typical experiment is presented. b The
effect of LOX inhibitors (Baicalein and NDGA) in APPsw cells on
p65 immunoreactivity was estimated by western blot. Baicalein was
used at 2.5 lM and NDGA at 0.5 lM. A representative western blot
from one typical experiment is below the graph. All data represent the
mean value ± S.E.M for 3 independent experiments normalized
against the immunoreactivity of b-actin. *P\0.05, ANOVA with
Bonferroni post-hoc test
Fig. 3 Mitochondrial AIF level and PARP-1 activity in PC12 cells
transfected with human APP. a The mitochondrial AIF protein level
and its gene expression (Aifm1) in PC12 control cells and APPwt or
APPsw. Protein level was estimated by western blot. AIF mRNA was
evaluated using Real Time PCR. The results are means ± S.E.M. of 4
experiments normalized against b-actin. b PARP-1 activity was
measured radiochemically with [
14C] NAD
? [27] in PC12 cell lines.
PARP-1 (Adpr1) mRNA was evaluated using Real Time PCR. The
data represent the mean value ± S.E.M for 3 independent experi-
ments (for PARP-1 activity in triplicate). *P\0.05, Student‘s t test
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123lines that secrete different amounts of Ab similar to the
concentrations observed previously [2, 3]. Our data dem-
onstrate a close relationship between this molecular events
in PC12 cells transfected with human APP gene bearing
double Swedish mutation (APPsw), secreted 5 times more
Ab comparing to control PC12 and 1,7 times more
comparing to APPwt. Moreover the level of free radicals
was signiﬁcantly higher in APPsw and also the liberation
of NO was enhanced in this cells line [2].
Free radicals serve as important mediators of
Ab-induced toxicity. Ab liberated nitric oxide (NO),
mediated molecular processes described previously by us
[3, 4]. It leads to liberation of arachidonic acid (AA), the
LOXs substrate. The enhanced activity of LOXs is con-
nected with the generation of the superoxide radical (O2
 -).
The interaction of O2
 - with NO
  can form peroxynitrite
(ONOO
-), which leads to the activation of free radicals
cascade and to oxidative stress. In this way NO, by regu-
lation of AA level, may be involved in enhancement in
LOX activity. On the basis of our results it is difﬁcult to
explain the mechanism of LOX activation. Several differ-
ent covalent modiﬁcation may occur. Until now, little is
known about regulation of LOX activity. Some studies
suggested, that dephosphorylation of LOX may by
responsible for the stimulation of enzyme activity [50].
Our data presented for the ﬁrst time the involvement of
LOX in Ab evoked free radicals signaling, that conse-
quently may lead to the enhancement of p65 level in
nuclear fraction, increase of AIF level in mitochondria and
to inhibition of PARP activity. Despite of several bio-
chemical and ultrastructural alterations described by us
[2–5], the signiﬁcant population of APPsw cells survive
during 24 h culturing indicated, that concomitantly with
degeneration processes several adaptive/protective mech-
anisms are activated. It seems that all these observations
are very important and could help to better understand the
mechanism of Ab toxicity in Alzheimer Disease (AD). To
this day, very few studies evaluated the sequence of events
connected with Ab mediated LOX pathway [37, 38].
Most studies were concentrated attention on cyclooxy-
genases (COX) the other family of enzymes involved in
AA metabolism. However, increase of 12/15 LOX and the
elevation of 12/15 LOX products were found in AD and in
mild cognitive impairment by Practico et al. and Yao et al.
[12, 51, 52]. Their results suggest that the activation of this
enzymes occurs early in the course of AD and that the
activation of LOXs mediated processes may play important
role in the pathogenesis of this disease.
The precise biological role for LOXs in the brain under
physiological condition and in AD has not yet be estab-
lished. A few other studies indicated the involvement of
5-LOX,12-LOX in neuronal death [15, 49, 53]. Our data
conﬁrmed the involvement of LOX in oxidative stress.
Transcription factor NF-jB may serve as an indicator of
the Ab/LOX-related free radical cascade. APPsw cells,
which display enhanced 12/15-LOX level and activity, had
higher nuclear levels of p65. This elevation of p65
immunoreactivity was suppressed by a speciﬁc inhibitor of
all lipoxygenases, NDGA. Additionally, signiﬁcantly
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Fig. 4 The role of LOX in SNP-induced PC12 cells death. a The
effect of SNP treatment on 12/15-LOX expression (Alox15). PC12
cells and PC12 expressing wt (APPwt) or mutated APP human gene
(APPsw) were treated with 0.5 mM SNP for 12 h. mRNA levels for
12/15-LOX was evaluated using Real Time PCR. The value expresses
the fold of Alox15 gene stimulation normalized against Actb (b-actin)
versus corresponding control (100%). b The effect of SNP treatment
on cell viability. PC12, APPwt and APPsw cells were treated with
0.5 mM SNP for 24 h, and cell viability was determined by the MTT
assay. c The effect of LOX inhibitors (Baicalein and NDGA) on the
viability of cells treated with 0.5 mM SNP for 24 h was determined
by MTT assay. Cells were incubated in the presence of LOX
inhibitors, 2.5 lM Baicalein and 0.5 lM NDGA. All values were
calculated as a percentage of control (without SNP) and are
means ± S.E.M for 4 independent experiments carried out in
triplicate or quadruplicate.
**P\0.01 versus PC12 control
(untreated),
###P\0.001 versus APPwt control (untreated),
$$P\0.01 versus APPsw control (untreated), *P\0.05 versus
SNP treated PC12 control, ANOVA with Bonferroni post-hoc test
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123increased mitochondrial AIF levels may suggest its pro-
tective role in APPsw cells. This protein possesses NADH
reductase activity and has anti-oxidative properties [39–
44]. Depending on the severity and duration of stress, AIF
levels can be responsible for cell survival or death. In
response to excessive stress, AIF may be translocated to the
nucleus, where it induces apoptosis or other forms of
programmed cell death [26, 31, 39]. It has been previously
shown that exogenous Ab activates the nuclear transloca-
tion of AIF [18, 45]. In this study, the endogenous pool of
Ab and its intracellular modiﬁcation may be responsible
for the increase in mitochondrial AIF level.
PARP-1 is another molecular target for stress signal-
ing. Under mild stress, it is involved in DNA repair;
however, massive oxidative stress could lead to PARP
over-activation and cell death. In addition, under signiﬁ-
cant oxidative stress, PARP-1 could be poly(ADP-ribosy-
lated) and inactivated [46, 47]. This covalent modiﬁcation
is probably responsible for the inhibition of this enzyme
activity in APPsw cells. Based on our results, it is difﬁcult
to judge what type of mechanism is responsible for
the signiﬁcant suppression of PARP-1 activity. The
NO-dependent mechanism of PARP-1 inhibition observed
in our previous studies [34] may also be involved in these
conditions. Moreover, Sidorkina et al. [47] showed that
PARP-1 activity may be directly suppressed via NO action.
In most studies, free radical-dependent DNA damage leads
to the activation of PARP-1 [48], such as in APPwt cells;
unfortunately the data are not signiﬁcant in the current
study. The suppression of PARP-1 activity in APPsw cells
probably plays a dual role: it leads to the alteration of
several processes and cell degeneration but may concur-
rently protect the cells against energy crises and allow most
of them to survive.
Despite the signiﬁcant enhancement of free radicals and
the dramatic biochemical and morphological alterations,
most of the APPwt and APPsw cells survived [2, 4, 5].
These data suggest that many different degenerative and
adaptive/protective processes were concurrently activated
in response to Ab toxicity. It seems that similar changes
may occur in brain cells during the early stages of AD. The
additional stress evoked by SNP overcomes these adaptive/
protective processes developed in the cells and leads to
death, more signiﬁcantly in the APPsw cells compared to
PC12 control cells. Enhanced NO production by constitu-
tive and inducible NO synthases was reported in PC12 cells
transfected with the APP gene in our previous work [2, 4].
To better understand the role of excessive nitrosative stress
in Ab peptide toxicity, we investigated the effect of the NO
donor, SNP.
Nitrosative stress caused by SNP led to signiﬁcant
12/15-LOX gene expression. The data show that LOX-
mediated death signaling occurs under nitrosative stress.
The LOX inhibitor protected cells against SNP-induced
death. The improvement in survival was greatest in the
APPsw-expressing cell line, which exhibited the lowest
survival rates without the inhibitors. Our current results add
to the evidence that supports the role of AA metabolism by
LOX in Ab evoked oxidative/nitrosative stress and in the
pathogenesis of AD.
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